Imagine living with a disease that causes excruciating pain, when every fever means a trip to the emergency room, where a stroke is a very real possibility. Children with sickle cell disease face these challenges. At this time, the only cure for this chronic, inherited condition — bone marrow transplantation — is so limited that relatively few procedures have been done. But major breakthroughs are near.
The Comprehensive Sickle Cell Center at Children’s Hospital of Philadelphia is one of the largest centers of its kind in the United States, caring for more than 1,000 patients annually. Our team of clinicians and researchers has pioneered breakthroughs that have dramatically improved the lives of children with sickle cell disease.
Our goals go far beyond treatment. Today, thanks to generous Blue Tag Gala supporters like you, we are on the verge of a potential cure for sickle cell disease.
But more remains to be done, and although there will not be a Blue Tag Gala for 2017, you can still help fund the discoveries that will transform children’s lives.
With your support, we will:
After 30 years of laboratory studies, we are now on the brink of a cutting-edge therapy to treat sickle cell disease before birth by using stem cells from the mother while babies are still in the womb. A landmark clinical trial is expected to begin soon.
Please support our sickle cell disease efforts by donating today.
To learn about other upcoming events that support Children’s Hospital of Philadelphia, see our event listing.